↓ Skip to main content

Caracterización de los eventos adversos a hidroxicloroquina, ivermectina, azitromicina y tocilizumab en pacientes hospitalizados por la COVID-19 en un hospital del Seguro Social de Salud del Perú

Overview of attention for article published in Revista Peruana de Medicina Experimental y Salud Pública, March 2023
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#46 of 472)
  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
10 X users

Readers on

mendeley
5 Mendeley